Development and validation of a clinical prediction model for sepsis-induced cardiomyopathy - Summary - MDSpire

Development and validation of a clinical prediction model for sepsis-induced cardiomyopathy

  • By

  • Tenghao Shao

  • Dan Su

  • Jinwen Zhang

  • Wenchao Kan

  • Yingxin Wang

  • Jiaqian Wu

  • Nan Zhang

  • Na Cui

  • Hongwei Zhang

  • July 17, 2026

Share

Objective:

To develop and validate a clinically applicable risk-prediction model for sepsis-induced cardiomyopathy (SICM) and to evaluate its predictive performance comprehensively.

Approach:
  • Study Design: A retrospective cohort study using clinical data from the MIMIC-IV database.
  • Data Analysis: Propensity score matching, univariate analysis, least absolute shrinkage and selection operator regression, and multivariate logistic regression were used.
  • Validation: The model was externally validated with an independent dataset of 104 patients.
Key Findings:
  • Five independent predictors were identified: serum phosphate concentration, neutrophil percentage, troponin concentration, heart rate, and Charlson Comorbidity Index from a cohort of 956 patients.
  • The model showed strong discriminatory ability with C-statistic values of 0.80 for the derivation cohort, 0.79 for the internal validation cohort, and 0.76 for the external validation cohort.
Interpretation:

The validated prediction model provides accurate estimation of SICM risk based on routinely available clinical variables.

Limitations:
  • The study is retrospective and may be subject to biases inherent in such designs.
  • The definition of SICM may not encompass all phenotypes of the condition.
Conclusion:

The model has potential utility for early risk stratification and individualized management of patients with sepsis.

Original Source(s)

Related Content